IL15 and melanoma: Furthermore, using hu-mouse-derived melanoma antigen-specific human T cells, we demonstrate that pretreatment of the T cells with rapamycin can significantly enhance the antitumor activity of adoptive T cell therapy in IL-15-treatted recipients.